18-74499978-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_018235.3(CNDP2):c.5C>T(p.Ala2Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000582 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
CNDP2
NM_018235.3 missense
NM_018235.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.79
Genes affected
CNDP2 (HGNC:24437): (carnosine dipeptidase 2) CNDP2, also known as tissue carnosinase and peptidase A (EC 3.4.13.18), is a nonspecific dipeptidase rather than a selective carnosinase (Teufel et al., 2003 [PubMed 12473676]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM1
In a modified_residue N-acetylalanine (size 0) in uniprot entity CNDP2_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.048279107).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNDP2 | NM_018235.3 | c.5C>T | p.Ala2Val | missense_variant | 2/12 | ENST00000324262.9 | NP_060705.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNDP2 | ENST00000324262.9 | c.5C>T | p.Ala2Val | missense_variant | 2/12 | 1 | NM_018235.3 | ENSP00000325548.4 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152164Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
48
AN:
152164
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251292Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135822
GnomAD3 exomes
AF:
AC:
26
AN:
251292
Hom.:
AF XY:
AC XY:
12
AN XY:
135822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461504Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 727084
GnomAD4 exome
AF:
AC:
46
AN:
1461504
Hom.:
Cov.:
30
AF XY:
AC XY:
14
AN XY:
727084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000315 AC: 48AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74454
GnomAD4 genome
AF:
AC:
48
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
24
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.5C>T (p.A2V) alteration is located in exon 2 (coding exon 1) of the CNDP2 gene. This alteration results from a C to T substitution at nucleotide position 5, causing the alanine (A) at amino acid position 2 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T;.;T;.;T;T;.;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;T;T;T;T;T;T;T;T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;.;.;.;.;.;.;.;.;L;.
PrimateAI
Benign
T
PROVEAN
Benign
.;N;.;.;.;.;.;.;.;.;.;.;N;.
REVEL
Benign
Sift
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;D;.
Sift4G
Uncertain
D;T;T;D;T;T;T;T;T;T;D;T;T;T
Polyphen
0.50, 0.32
.;P;P;.;.;.;.;.;.;.;.;.;B;.
Vest4
0.22, 0.27, 0.18, 0.24
MVP
MPC
0.17
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at